Page 43 - 南京医科大学学报自然科学版
P. 43
第42卷第10期 马牧溪,张发财,王明生,等. 基于TCGA数据库的肾透明细胞癌miRNA预后模型的构建及
2022年10月 蛋白互作网络分析[J]. 南京医科大学学报(自然科学版),2022,42(10):1376-1386 ·1385 ·
[7] CAO J,LIU J,XU R,et al. microRNA⁃21 stimulates epi⁃ [20] LISA K,EDUARD R,DIETHER L,et al. microRNAs pos⁃
thelial ⁃ to ⁃ mesenchymal transition and tumorigenesis in sibly involved in the development of bone metastasis in
clear cell renal cells[J]. Mol Med Rep,2016,13(1):75- clear⁃cell renal cell carcinoma[J]. Cancers,2021,13(7):
82 1554
[8] 张 飞,史成宇,杨世坤,等. miR⁃1301对肝细胞肝癌增 [21] HES O,COMPÉRAT E M,RIOUX⁃LECLERCQ N. Clear
殖的影响及机制研究[J]. 南京医科大学学报(自然科学 cell papillary renal cell carcinoma,renal angiomyoadeno⁃
版),2020,40(3):355-359 matous tumor,and renal cell carcinoma with leiomyoma⁃
[9] CAO Y J,XU R F,XU X L,et al. Downregulation of ln⁃ tous stroma relationship of 3 types of renal tumors:a re⁃
cRNA CASC2 by microRNA ⁃ 21 increases the prolifera⁃ view[J]. Ann Diagn Pathol,2016,21:59-64
tion and migration of renal cell carcinoma cells[J]. Mol [22] MAKHOV P,JOSHI S,GHATALIA P,et al. Resistance
Med Rep,2016,14(1):1019-1025 to systemic therapies in clear cell renal cell carcinoma:
[10] 邓 威,孟 颖,王晨星,等. miR⁃182在口腔鳞癌血清 mechanisms and management strategies[J]. Mol Cancer
外泌体中的表达及其临床意义[J]. 南京医科大学学报 Ther,2018,17(7):1355-1364
(自然科学版),2021,41(4):509-515 [23] LJUNGBERG B,ALBIGES L,ABU⁃GHANEM Y,et al.
[11] TSAI M M,WANG C S,TSAI C Y,et al. Potential diag⁃ European association of urology guidelines on renal cell
nostic,prognostic and therapeutic targets of microRNAs carcinoma:the 2019 update[J]. Eur Urol,2019,75(5):
in human gastric cancer[J]. Int J Mol Sci,2016,17(6): 799-810
945 [24] 于伟华. miR⁃21⁃5p靶向CHL1促进结肠腺癌发生发展
[12] LARRABEITI ⁃ ETXEBARRIA A,LOPEZ ⁃ SANTILLAN 及作用机制的研究[D]. 济南:山东大学,2019
M,SANTOS⁃ZORROZUA B,et al. Systematic review of [25] 柯井卫,沈宏春,刘 星,等. 骨髓间充质干细胞源外泌
the potential of microRNAs in diffuse large B cell lympho⁃ 体 miR⁃21⁃5p 通过下调 PHLPP2 促进前列腺癌 PC⁃3 细
ma[J]. Cancers,2019,11(2):144-144 胞的增殖、迁移和侵袭[J]. 中国肿瘤生物治疗杂志,
[13] LU S,ZHOU C,ZOU B W,et al. miR⁃4295 facilitates cell 2020,27(5):534-540
proliferation and metastasis in head and neck squamous [26] HAN S S,WANG L,SUN L K,et al. microRNA⁃1251⁃5p
cell carcinoma by targeting NPTX1[J]. Genes Immun, promotes tumor growth and metastasis of hepatocellular
2020,21(1):4-12 carcinoma by targeting AKAP12[J]. Biomed Pharmacoth⁃
[14] LIAO H,LIANG Y,KANG L,et al. miR⁃454⁃3p inhibits er,2020,122:109754
non⁃small cell lung cancer cell proliferation and metasta⁃ [27] YAO D Y,XIA S Y,JIN C J,et al. Feedback activation of
sis by targeting TGFB2[J]. Oncol Rep,2021,45(5):67 GATA1/miR⁃885⁃5p/PLIN3 pathway decreases sunitinib
[15] GUO J Y,LUO C,YANG Y Q,et al. miR⁃491⁃5p,as a tu⁃ sensitivity in clear cell renal cell carcinoma[J]. Cell Cy⁃
mor suppressor,prevents migration and invasion of breast cle Georget Tex,2020,19(17):2195-2206
cancer by targeting ZNF⁃703 to regulate AKT/mTOR path⁃ [28] 房 昕,孙 汝,胡玉鑫,等. miR⁃182⁃5p/HIF2α通路在
way[J]. Cancer Manag Res,2021,13:403-413 无机砷恶性转化人肾小管上皮细胞中的作用[C]//
[16] DING L F,JIANG M X,WANG R Y,et al. The emerging 2018环境与健康学术会议⁃精准环境健康:跨学科合作
role of small non⁃coding RNA in renal cell carcinoma[J]. 的挑战论文汇编. 沈阳:中国毒理学会,2018
Transl Oncol,2021,14(1):100974 [29] 许轶涵,李 晨,郭钊培,等. 血清IgG N⁃聚糖在肿瘤辅
[17] QI Y J,WANG L,WANG K Z,et al. New mechanistic in⁃ 助诊断中的研究现状[J]. 国际检验医学杂志,2021,42
sights of clear cell renal cell carcinoma from integrated (7):877-880
miRNA and mRNA expression profiling studies[J]. [30] ZHANG D,LI X O,LIU X F,et al. Disease⁃specific IgG
Biomed Pharmacother,2019,111:821-834 fc glycosylation ratios as personalized biomarkers to dif⁃
[18] QIN S J,SHI X J,WANG C B,et al. Transcription factor ferentiate non ⁃ small cell lung cancer from benign lung
and miRNA interplays can manifest the survival of diseases[J]. Proteom Clin Appl,2020,14(1):e1900016
ccRCC patients[J]. Cancers,2019,11(11):1668 [31] ZOU Y,HU J X,JIE J Z,et al. Comprehensive analysis of
[19] XIE M Z,LV Y F,LIU Z H,et al. Identification and vali⁃ human IgG Fc N ⁃ glycopeptides and construction of a
dation of a four⁃miRNA(miRNA⁃21⁃5p,miRNA⁃9⁃5p, screening model for colorectal cancer[J]. J Proteom,
miR⁃149⁃5p,and miRNA⁃30b⁃5p)prognosis signature in 2020,213:103616
clear cell renal cell carcinoma[J]. Cancer Manag Res, [32] MATSUMOTO T,HATAKEYAMA S,YONEYAMA T,et
2018,10:5759-5766 al. Serum N⁃glycan profiling is a potential biomarker for